Article 223-16 du Règlement Général de l’Autorité des Marchés Financiers http://novacyt.com/wp-content/uploads/2019/03/Contrat-de-liquidité-1-mars-2019.pdf
Visit PageYear: 2019
Liquidity Agreement Monthly Update and Total Voting Rights
Paris, France and Camberley, UK – 1 March 2019 – Novacyt (EURONEXT GROWTH: ALNOV; AIM: NCYT), an international specialist in clinical diagnostics, today announces its monthly update in relation to ordinary shares traded under its ongoing liquidity agreement with Invest Securities SA (the “Liquidity Agreement”). The Liquidity Agreement is governed by French law and is further summarised
Visit PageINFORMATION SUR LE FINANCEMENT
INFORMATION SUR LE FINANCEMENT Paris, France et Camberley, UK – 26 février 2019 – Novacyt (EURONEXT GROWTH : ALNOV ; AIM : NCYT), spécialiste international du diagnostic clinique informe sur sa position financière actuelle et ses plans de financement. La Société confirme que l’exercice 2019 a débuté positivement et qu’il est conforme aux attentes du
Visit Page